415 related articles for article (PubMed ID: 24508139)
1. Unexpected coronary artery findings in mucopolysaccharidosis. Report of four cases and literature review.
Braunlin E; Orchard PJ; Whitley CB; Schroeder L; Reed RC; Manivel JC
Cardiovasc Pathol; 2014; 23(3):145-51. PubMed ID: 24508139
[TBL] [Abstract][Full Text] [Related]
2. Aortic Root Dilatation in Mucopolysaccharidosis I-VII.
Bolourchi M; Renella P; Wang RY
Int J Mol Sci; 2016 Nov; 17(12):. PubMed ID: 27916847
[TBL] [Abstract][Full Text] [Related]
3. Clear cells in the atrioventricular valves of infants with severe human mucopolysaccharidosis (Hurler syndrome) are activated valvular interstitial cells.
Braunlin E; Tolar J; Mackey-Bojack S; Masinde T; Krivit W; Schoen FJ
Cardiovasc Pathol; 2011; 20(5):315-21. PubMed ID: 20619689
[TBL] [Abstract][Full Text] [Related]
4. Characterization of pulmonary function impairments in patients with mucopolysaccharidoses--changes with age and treatment.
Lin SP; Shih SC; Chuang CK; Lee KS; Chen MR; Niu DM; Chiu PC; Lin SJ; Lin HY
Pediatr Pulmonol; 2014 Mar; 49(3):277-84. PubMed ID: 23401495
[TBL] [Abstract][Full Text] [Related]
5. Impaired elastogenesis in Hurler disease: dermatan sulfate accumulation linked to deficiency in elastin-binding protein and elastic fiber assembly.
Hinek A; Wilson SE
Am J Pathol; 2000 Mar; 156(3):925-38. PubMed ID: 10702409
[TBL] [Abstract][Full Text] [Related]
6. Outcome in six children with mucopolysaccharidosis type IH, Hurler syndrome, after haematopoietic stem cell transplantation (HSCT).
Malm G; Gustafsson B; Berglund G; Lindström M; Naess K; Borgström B; von Döbeln U; Ringdén O
Acta Paediatr; 2008 Aug; 97(8):1108-12. PubMed ID: 18452566
[TBL] [Abstract][Full Text] [Related]
7. Mucopolysaccharidoses type I and IVA: clinical features and consanguinity in Tunisia.
Khedhiri S; Chkioua L; Bouzidi H; Dandana A; Ben Turkia H; Miled A; Laradi S
Pathol Biol (Paris); 2009 Jul; 57(5):392-7. PubMed ID: 18584975
[TBL] [Abstract][Full Text] [Related]
8. Mucopolysaccharidosis type I.
Wraith JE; Jones S
Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():102-6. PubMed ID: 25345091
[TBL] [Abstract][Full Text] [Related]
9. Substrate accumulation and extracellular matrix remodelling promote persistent upper airway disease in mucopolysaccharidosis patients on enzyme replacement therapy.
Pal AR; Mercer J; Jones SA; Bruce IA; Bigger BW
PLoS One; 2018; 13(9):e0203216. PubMed ID: 30226843
[TBL] [Abstract][Full Text] [Related]
10. Light and electron microscopic features of the liver in mucopolysaccharidosis.
Resnick JM; Whitley CB; Leonard AS; Krivit W; Snover DC
Hum Pathol; 1994 Mar; 25(3):276-86. PubMed ID: 8150458
[TBL] [Abstract][Full Text] [Related]
11. Enzyme replacement therapy in patients who have mucopolysaccharidosis I and are younger than 5 years: results of a multinational study of recombinant human alpha-L-iduronidase (laronidase).
Wraith JE; Beck M; Lane R; van der Ploeg A; Shapiro E; Xue Y; Kakkis ED; Guffon N
Pediatrics; 2007 Jul; 120(1):e37-46. PubMed ID: 17606547
[TBL] [Abstract][Full Text] [Related]
12. The natural history of neurocognition in MPS disorders: A review.
Shapiro EG; Eisengart JB
Mol Genet Metab; 2021 May; 133(1):8-34. PubMed ID: 33741271
[TBL] [Abstract][Full Text] [Related]
13. Rapid identification of San Filippo disease (MPS III).
Kelly S; Schedlbauer L; Leikhim E
Health Lab Sci; 1978 Jul; 15(3):123-7. PubMed ID: 151669
[TBL] [Abstract][Full Text] [Related]
14. Residual α-L-iduronidase activity in fibroblasts of mild to severe Mucopolysaccharidosis type I patients.
Oussoren E; Keulemans J; van Diggelen OP; Oemardien LF; Timmermans RG; van der Ploeg AT; Ruijter GJ
Mol Genet Metab; 2013 Aug; 109(4):377-81. PubMed ID: 23786846
[TBL] [Abstract][Full Text] [Related]
15. Metabolic Syndrome and Cardiovascular Risk Factors after Hematopoietic Cell Transplantation in Severe Mucopolysaccharidosis Type I (Hurler Syndrome).
Braunlin E; Steinberger J; DeFor T; Orchard P; Kelly AS
Biol Blood Marrow Transplant; 2018 Jun; 24(6):1289-1293. PubMed ID: 29409846
[TBL] [Abstract][Full Text] [Related]
16. Coronary artery luminal narrowing in the young with sudden unexpected death: a coroner's autopsy study in 350 subjects age 40 years and under.
Mizgala HF; Gray LH; Ferris JA; Bociek V; Allard P; Davies C
Can J Cardiol; 1993; 9(1):33-40. PubMed ID: 8439827
[TBL] [Abstract][Full Text] [Related]
17. Cardiac functional and histopathologic findings in humans and mice with mucopolysaccharidosis type I: implications for assessment of therapeutic interventions in hurler syndrome.
Braunlin E; Mackey-Bojack S; Panoskaltsis-Mortari A; Berry JM; McElmurry RT; Riddle M; Sun LY; Clarke LA; Tolar J; Blazar BR
Pediatr Res; 2006 Jan; 59(1):27-32. PubMed ID: 16326988
[TBL] [Abstract][Full Text] [Related]
18. Hepatic fibrosis in the mucopolysaccharidoses.
Parfrey NA; Hutchins GM
Am J Med; 1986 Nov; 81(5):825-9. PubMed ID: 3096134
[TBL] [Abstract][Full Text] [Related]
19. The mucopolysaccharidoses and mucolipidoses.
Kelly TE
Clin Orthop Relat Res; 1976; (114):116-33. PubMed ID: 131015
[TBL] [Abstract][Full Text] [Related]
20. Combined enzyme replacement and haematopoietic stem cell transplantation in Hurler syndrome.
Bijarnia S; Shaw P; Vimpani A; Smith R; Pacey V; O'Grady H; Christodoulou J; Sillence D
J Paediatr Child Health; 2009; 45(7-8):469-72. PubMed ID: 19712183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
